162 results found
Merck Sharp & Dohme Corp., MK-3475-158, KEYNOTE, Ph 2, Multiple Tumor Types, Pembrolizumab
This study focuses on patients diagnosed with an advanced solid tumor that meets specific criteria. The purpose of the study is to evaluate the investigational use of a drug called pembrolizumab (MK-3475), which may help ...
CSMC, IIT2015-14-POSADAS-VSNCTC, ph n/a Prostate, VSNC Tumor cells, visc mets prediction
To measure the predictive value of vsnCTCs for detection and/or prediction of VM in CRPC.
Pfizer, IIT2016-03-POSADAS-PBRCC , P N/A, RCC, predictive blood biomarkers
To determine the feasibility of detecting ctDNA, CTCs, and LO in patients with metastatic kidney cancer who are in need of therapy or who are receiving therapy
CSMC, IIT2016-09-LABADZHYAN-ICI, met ca, predictive markers/endocrine hormone changes
Aim 1: To show that specific endocrine related antibodies, known to be associated with endocrine gland failure, are a good predictive marker for development of endocrine related adverse events (ERAE) in patients with metastatic cancers ...
IIT2016-18-SHIAO-NEOADSRS, Ph 1, Open label, Brain metastases, SRS
Radiosurgery is a non-surgical radiation treatment that can deliver targeted radiation to small lesions in the brain. For brain metastases, radiation is typically given after a patient has healed from surgery to remove a tumor in ...